fluorouracil has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Chen, Y; Huang, R; Li, J; Liu, Z; Muhammand, S; Song, Y; Tang, Q; Wang, G; Wang, X; You, Q; Zhang, Q | 1 |
Gong, L; Gross, N; Lei, D; Li, G; Li, X; Luo, X; Zeng, Q; Zhang, M; Zhang, S; Zhang, Z; Zhou, Z | 1 |
3 other study(ies) available for fluorouracil and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Topics: AC133 Antigen; Amyloid Precursor Protein Secretases; Animals; Antigens, CD; Antineoplastic Agents; Cell Proliferation; Colorectal Neoplasms; Dipeptides; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Glycoproteins; HCT116 Cells; Humans; Hyaluronan Receptors; Injections, Intraperitoneal; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Organoplatinum Compounds; Oxaliplatin; Peptides; Phenotype; Receptors, Notch; Signal Transduction; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2015 |
High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.
Topics: Adult; Aged; Antineoplastic Agents; Cell Line, Tumor; Chemotherapy, Adjuvant; Cisplatin; Dipeptides; Disease-Free Survival; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Receptor, Notch1; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2019 |